REVIEW OF THE PHYTOTHERAPY FOR NEPHROLITHIASIS

Hanna Salwa Ridwan, S. Megantara, J. Levita
{"title":"REVIEW OF THE PHYTOTHERAPY FOR NEPHROLITHIASIS","authors":"Hanna Salwa Ridwan, S. Megantara, J. Levita","doi":"10.52434/jifb.v15i1.2877","DOIUrl":null,"url":null,"abstract":"Nephrolithiasis (kidney stone) cases have a prevalence ranging from 1% to 13%. The disease not only hampers kidney function but also elevates the risk of chronic kidney diseases. The pathophysiology of nephrolithiasis is closely linked to elevated concentrations of calcium, oxalate, and/or uric acid in the urine. Pharmacotherapy to manage nephrolithiasis includes thiazide diuretics, allopurinol, citrate supplements, and alpha-blockers that have been prescribed to relieve symptoms. In addition, there is growing interest in exploring the potential of phytotherapy. This review aims to identify suitable phytotherapy approaches by examining relevant articles on nephrolithiasis. The research methodology involved searching PubMed articles using the keywords of ((\"Plant Extracts\") AND (\"Nephrolithiasis\")) OR (\"Ureterolithiasis\"). The articles obtained from the initial search were n =123. 2 authors screened articles for their eligibility. The inclusion criteria were limited to articles written in English, topics related to nephrolithiasis and not other kidney diseases, the botanical names of the plants and the method of extraction are clearly described, complete studies with clear descriptions regarding the methods and results, not synthetic drugs, and not involving medical instruments or laser to remove the stones. Articles included in the review were n = 17. Water and hydro-alcohol were the solvents used to extract the plants. Twenty-two plants have confirmed their anti-nephrolithiasis activity, and nine articles described the assay by in vivo study, two by in vitro study, three by both in vitro and in vivo study, and only one article mentioned a study in humans by a randomized-control trial on a mixture of herbs. It is concluded that Rhizoma alismatis, Poria cocos, Polyporus umbellatus, Atractylodis macrocephalae, and Cinnamomi Cassiae prepared as a mixture in the Wu-Ling-San formula have a potential therapeutic effect on nephrolithiasis, as this formula has been studied in humans.","PeriodicalId":197039,"journal":{"name":"Jurnal Ilmiah Farmako Bahari","volume":"88 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jurnal Ilmiah Farmako Bahari","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52434/jifb.v15i1.2877","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Nephrolithiasis (kidney stone) cases have a prevalence ranging from 1% to 13%. The disease not only hampers kidney function but also elevates the risk of chronic kidney diseases. The pathophysiology of nephrolithiasis is closely linked to elevated concentrations of calcium, oxalate, and/or uric acid in the urine. Pharmacotherapy to manage nephrolithiasis includes thiazide diuretics, allopurinol, citrate supplements, and alpha-blockers that have been prescribed to relieve symptoms. In addition, there is growing interest in exploring the potential of phytotherapy. This review aims to identify suitable phytotherapy approaches by examining relevant articles on nephrolithiasis. The research methodology involved searching PubMed articles using the keywords of (("Plant Extracts") AND ("Nephrolithiasis")) OR ("Ureterolithiasis"). The articles obtained from the initial search were n =123. 2 authors screened articles for their eligibility. The inclusion criteria were limited to articles written in English, topics related to nephrolithiasis and not other kidney diseases, the botanical names of the plants and the method of extraction are clearly described, complete studies with clear descriptions regarding the methods and results, not synthetic drugs, and not involving medical instruments or laser to remove the stones. Articles included in the review were n = 17. Water and hydro-alcohol were the solvents used to extract the plants. Twenty-two plants have confirmed their anti-nephrolithiasis activity, and nine articles described the assay by in vivo study, two by in vitro study, three by both in vitro and in vivo study, and only one article mentioned a study in humans by a randomized-control trial on a mixture of herbs. It is concluded that Rhizoma alismatis, Poria cocos, Polyporus umbellatus, Atractylodis macrocephalae, and Cinnamomi Cassiae prepared as a mixture in the Wu-Ling-San formula have a potential therapeutic effect on nephrolithiasis, as this formula has been studied in humans.
肾炎植物疗法综述
肾结石的发病率从 1%到 13%不等。这种疾病不仅会影响肾功能,还会增加患慢性肾病的风险。肾结石的病理生理学与尿液中钙、草酸盐和/或尿酸浓度升高密切相关。控制肾炎的药物疗法包括噻嗪类利尿剂、别嘌呤醇、枸橼酸盐补充剂和α-受体阻滞剂,这些药物已被用于缓解症状。此外,人们对探索植物疗法的潜力也越来越感兴趣。本综述旨在通过研究肾炎的相关文章,找出合适的植物疗法方法。研究方法包括使用关键字(("植物提取物")和("肾结石"))或(("输尿管结石")搜索 PubMed 上的文章。或("输尿管结石")。初步搜索得到的文章数量为 123 篇。两名作者对文章进行了资格筛选。纳入标准仅限于用英语撰写的文章,主题与肾结石而非其他肾脏疾病相关,清楚描述了植物的名称和提取方法,研究完整,方法和结果描述清楚,非合成药物,不涉及医疗器械或激光取石。纳入综述的文章 n = 17。水和水醇是提取植物的溶剂。有 22 种植物被证实具有抗肾结石活性,其中 9 篇文章通过体内研究进行了描述,2 篇通过体外研究进行了描述,3 篇通过体外和体内研究进行了描述,只有 1 篇文章提到了通过随机对照试验对草药混合物进行的人体研究。结论是五苓散方中的黄精、茯苓、伞形科植物白术和桂枝的混合物对肾结石有潜在的治疗作用,因为该方已在人体中进行过研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信